Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by ...

Could nuclear energy revolutionize Tesla’s charging systems? Explore the fascinating history of nuclear-powered concepts and ...